Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-28

Clinical Trial Results: A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating NT 201 (Botulinum Toxin) vs placebo for essential tremor in the upper limb has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NT 201 (Botulinum toxin) (Botulinum toxin type A)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Essential Tremor of the Upper Limb | Phase 2 | Status: COMPLETED | Results posted: 2026-04-28